Click to Share
 

Filter News
Show All Results
News By Country
News By Tag
Medical Remove


June 2025
ThWeTuMoSuSaFr
19181716151413

Public Company News

Business Press Releases

Medical Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

Premium Press Releases | Show All

13080691
By Corporate Ads
NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Has $7.8 Million in Financing for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal Depression / PTSD
By Laube
As a recognized leader in titanium supply and engineered metal solutions, Laube Technology is excited to connect with the innovators shaping the future of orthopedics.
13078011
By Corporate Ads
$NRXP Closing $7.8 Million in Financing for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute Treatment Model and Leading Investigative Site
13076994
By Corporate Ads
$NRXP NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP): Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties
13076537
By Corporate Ads
NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties
13076525
By Corporate Ads
Cadrenal Therapeutics, Inc. (Stock Symbol: CVKD) $CVKD Tecarfarin Anticoagulant Reduces Drug on Drug Interactions Which Pose a Major Issue with Warfarin. Successful Phase III Could Enhance Liquidity and Quickly Attract Large Institutional Investors.
13075346
By Corporate Ads
$BEAT Clinical Endpoints Successfully Met in Pivotal Study, Plus FDA Clearance for At-Home, High-Fidelity Heart Monitoring System.
13075109
By Corporate Ads
$NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties. NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
13074425
By Corporate Ads
$300 Million Set up in Milestones for $NRXP on Tiered Double-Digit Royalties
By AHIH
The Association for Hospitality in Healthcare (AHIH), a new professional association committed to the discovery, review, and dissemination of evidence-based information on how hospitality services can enhance the patient experience in the delivery of...
13074054
By Corporate Ads
$BEAT Forms Strategic Collaboration with AccurKardia for Ambulatory ECG Recording and Analysis to Advance Cardiac Monitoring Care. HeartBeam, Inc. (Stock Symbol: BEAT)
13069875
By Corporate Ads
NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties

All Press Releases

13080691
By Corporate Ads
NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Has $7.8 Million in Financing for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal Depression / PTSD
By Laube
As a recognized leader in titanium supply and engineered metal solutions, Laube Technology is excited to connect with the innovators shaping the future of orthopedics.
By aquigenbio
In the world of pharmaceutical development and analytical testing, the quality and reliability of reference standards are non-negotiable. This is particularly true when working with Dabigatran, a direct thrombin inhibitor widely used in anticoagulant
By UROK PHARMA
Iraq's premier pharmaceutical leader, Urok Pharma, secures exclusive international certifications, delivering unmatched quality and redefining healthcare innovation in the region and beyond.
By aquigenbio
Unraveling Mirtazapine Nitroso Impurity 2 and the Growing Concern Over Nitrosamine Contaminants in Pharmaceuticals
13078011
By Corporate Ads
$NRXP Closing $7.8 Million in Financing for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute Treatment Model and Leading Investigative Site
13076994
By Corporate Ads
$NRXP NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP): Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties
13076537
By Corporate Ads
NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties
13076525
By Corporate Ads
Cadrenal Therapeutics, Inc. (Stock Symbol: CVKD) $CVKD Tecarfarin Anticoagulant Reduces Drug on Drug Interactions Which Pose a Major Issue with Warfarin. Successful Phase III Could Enhance Liquidity and Quickly Attract Large Institutional Investors.
13075346
By Corporate Ads
$BEAT Clinical Endpoints Successfully Met in Pivotal Study, Plus FDA Clearance for At-Home, High-Fidelity Heart Monitoring System.
13075109
By Corporate Ads
$NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties. NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
13074425
By Corporate Ads
$300 Million Set up in Milestones for $NRXP on Tiered Double-Digit Royalties
By AHIH
The Association for Hospitality in Healthcare (AHIH), a new professional association committed to the discovery, review, and dissemination of evidence-based information on how hospitality services can enhance the patient experience in the delivery of...
13074054
By Corporate Ads
$BEAT Forms Strategic Collaboration with AccurKardia for Ambulatory ECG Recording and Analysis to Advance Cardiac Monitoring Care. HeartBeam, Inc. (Stock Symbol: BEAT)
By GUBERMAN-PMC.LLC
An Exposé On Vaccine Quality, Global Accreditation Failures, And The Standards That Betrayed Us
13069875
By Corporate Ads
NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties
13068083
By Corporate Ads
NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP): License and Distribution Terms Set for Lucrative Suicide Depression Treatment; $31 Price Target from Respected Investment Analyst D. Boral Capital
13067553
By Dentaluxe
Premier Dental Implant Center Dentaluxe Unveils Cutting-Edge New Website to Enhance Patient Experience in Jacksonville, Florida
By SmartFinancial
For the full article and more on how to file and how the process works, visit link at end.
13066906
By Corporate Ads
$NRXP is Poised to Address the $3 Billion + Suicidal Depression Market in the US
By Ajantha Public Relations
Hyderabad, March 16: It is an undeniable fact that quackery exists in the state, but complete eradication is not immediately possible, said Professor Kodandaram, Chief Advisor to the Government. However, he expressed his readiness to regulate it.
13063486
By Spencer Lewis Marketing Group
Company Solidifies Commitment to World-Class Quality Standards Across Aerospace, Automotive, Medical, and Consumer Industries
13062986
By Spark Design Awards
The Spark Design Organization welcomes entries from around the world to compete for the coveted Platinum, Gold, Silver, Bronze Spark Awards. Judges choose professional and student winners from all design categories
By Ajantha Public Relations
The Indian Medical Association (IMA) Telangana State Committee has strongly urged political parties to immediately stop encouraging unqualified quack doctors for electoral benefits. In a statement, IMA Telangana President Dr.
13059022
By Corporate Ads
$NRXP given a $31 Price Target from Respected Investment Analyst D. Boral Capital
By BookBuzz
Introducing It's My Life: My Personal Record of Everything Important A Practical and Essential Guide to Organizing Your Personal Information Sheena J.
By BookBuzz
Dr. Jim Longobardi is pleased to announce the release of his new book, Patience with Patients: Reviving Bedside Manner, a timely and thought-provoking examination of the critical role empathy plays in modern healthcare.
By Sunday Health
New Sunday Health Vienna, VA Office Offers Confidential, No-Cost Cognitive Screenings and Educational Resources About Modifiable Risk Factors for Dementia
13056145
By Corporate Ads
$NRXP $31 Price Target from Respected Investment Analyst D. Boral Capital
13055392
By Corporate Ads
$NRXP New Drug Application for Treatment of Suicidal Depression. Completion of NDA Filing Expected in First Quarter of 2025
13054938
By Corporate Ads
NRx Pharmaceuticals, Inc.: Stock Symbol: NRXP IS Aiming to be the First FDA-Approved Medication to Treat Suicidal Depression

Page: 1 2 NextPage updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share